SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is experiencing heightened volatility and community speculation as investors debate the impact of potential strategic moves involving eBay and the conversion of convertible notes into equity. While some shareholders express frustration over recent price stagnation and dilution, others remain focused on the company's strengthened cash position and the ongoing anticipation of a major long-term catalyst.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is seeing heightened community discussion as investors pivot focus toward upcoming quarterly results, with many debating whether the stock's recent price consolidation will lead to a breakout or a sharp post-earnings move. While sentiment remains divided between concerns over current valuation multiples and optimism regarding enterprise AI adoption, market participants are actively monitoring implied volatility and the company's ability to maintain high revenue growth.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate whether recent price volatility is a temporary setback driven by sector rotation or a fundamental shift in the company's competitiveness against AI-integrated platforms. The community remains divided between long-term bulls highlighting strong balance sheet fundamentals and share buybacks, and skeptics who are concerned about mounting short interest and the competitive threat from larger enterprise software incumbents.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is facing intense volatility as traders weigh a major insider lock-up expiration against an upcoming first public earnings report. The community remains deeply divided, with bears pointing to massive potential share dilution while bulls view the pullback as a long-term entry opportunity for a company central to the future space economy.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is seeing increased investor focus driven by news of its collaboration with Janux Therapeutics and continued pipeline activity, including upcoming clinical milestones and pipeline updates. Market participants are actively discussing the company's efforts to navigate patent cliffs while managing its growth portfolio, with sentiment reflecting a balance of optimism for its pipeline potential and caution regarding legacy revenue pressures.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is trending following the company's final regulatory approval from the OCC to establish a national trust bank, a milestone that investors view as a significant step in legitimizing its digital asset infrastructure. Despite this positive catalyst, the stock remains a focal point for intense community debate, with bulls highlighting the long-term institutional potential while bears point to persistent short-term selling pressure and ongoing competition in the stablecoin sector.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca's stock is experiencing increased volatility following reports that the company is in preliminary talks with Bristol Myers Squibb regarding a potential $400 billion merger centered on oncology assets. While the pharmaceutical community is actively debating the significant portfolio synergies and antitrust hurdles of such a massive combination, investors are closely watching how the news impacts the company's long-term growth narrative and near-term price stability.

JinkoSolar Holding Co., Ltd. engages in the manufacture of solar modules. It distributes solar products and sells its solutions and services to a diversified international utility, commercial and residential customers. The company was founded by Xian De Li, Kang Ping Chen, and Xian Hua Li in June 2006 and is headquartered in Shangrao, China.

JinkoSolar Holding Co. Ltd - ADR

JinkoSolar Holding Co LTD

JinkoSolar is trending due to its exceptionally low valuation, with community members highlighting a market capitalization that is only a fraction of its multibillion-dollar annual revenue. Investors are actively discussing the company's strong global order flow, its triple-A bankability rating, and the potential for a share price rerating driven by management's buyback authorization and strong financial fundamentals.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors react to bullish sentiment, anticipation of upcoming financial results, and optimism surrounding potential corporate actions like relisting and share buybacks. The community is actively discussing the company's aggressive store expansion and digital-first business model, with many debating the impact of competitive pricing strategies and market position against major peers.

ProShares Trust II - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

ProShares UltraShort Bloomberg Crude Oil (SCO) is attracting heavy trading volume as investors react to fluctuating Middle East tensions and shifting OPEC+ production policies. The community remains deeply divided, with many debating the impact of leveraged ETF decay against tactical bets on a potential de-escalation in regional oil supply disruptions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About LB Pharmaceuticals Inc (LBRX) Rating Upgrade to Buy

LB Pharmaceuticals Inc (LBRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LB Pharmaceuticals (NASDAQ:LBRX) Raised to "Strong-Buy" at HC Wainwright

HC Wainwright upgraded shares of LB Pharmaceuticals to a "strong-buy" rating in a research note on Monday...

LB Pharmaceuticals (NASDAQ:LBRX) Hits New 52-Week High  - What's Next?

LB Pharmaceuticals (NASDAQ:LBRX) Reaches New 52-Week High - Here's Why...

LB Pharmaceuticals (NASDAQ:LBRX) Trading 5.6% Higher - Time to Buy?

LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Up 5.6% - Time to Buy...

LB Pharmaceuticals (NASDAQ:LBRX) Sets New 52-Week High - Time to Buy?

LB Pharmaceuticals (NASDAQ:LBRX) Sets New 52-Week High - Should You Buy...

LB Pharmaceuticals Highlights LB-102 Phase 3 Schizophrenia Path, Funding Runway to 2029 at Needham

LB Pharmaceuticals (NASDAQ:LBRX) is seeking to build a "fully integrated company focused on CNS-related diseases," Chief Executive Officer Heather Turner said during a presentation at a Needham conference hosted by biotech analyst Ami Fadia.

Turner said the company's lead program, LB-102, is a late...

LB Pharmaceuticals (NASDAQ:LBRX) Shares Down 4.5% - Should You Sell?

LB Pharmaceuticals (NASDAQ:LBRX) Trading Down 4.5% - Here's Why...

LB Pharmaceuticals (NASDAQ:LBRX) Reaches New 1-Year High - Should You Buy?

LB Pharmaceuticals (NASDAQ:LBRX) Reaches New 12-Month High - Here's Why...

LB Pharmaceuticals (NASDAQ:LBRX) Now Covered by Analysts at Craig Hallum

Craig Hallum began coverage on LB Pharmaceuticals in a research report on Friday. They issued a "buy" rating and a $36.00 price objective on the stock...

LB Pharmaceuticals (NASDAQ:LBRX) Trading Down 6.1% - Here's What Happened

LB Pharmaceuticals (NASDAQ:LBRX) Trading Down 6.1% - What's Next...

LB Pharmaceuticals, Inc. engages in the research and development of novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its product pipeline includes LB-102, is a Phase 3-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms. The company was founded by Vince Grattan and Zachary Prensky in 2015 and is headquartered in New York.

LB Pharmaceuticals Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info